Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 364 followers
Latest posts
Last updated about 5 hours ago
AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap
about 5 hours ago
A new commercial for AstraZeneca’s Truqap constructs a vision of the extra...
As vaccine sales slip, GSK touts 'mitigation options' for potential drug tariffs
about 6 hours ago
GSK says it has identified "mitigation options" to navigate potential U.S. pharmaceutical...
Sanofi nets €10B from Opella sale, eyes more 'bolt-on' deals
about 6 hours ago
Six months after entering talks with U.S. private equity firm Clayton, Dubilier...
J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy
about 7 hours ago
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy...
Charles Barkley boards Ro's GLP-1 ad push, signing up to take a 2nd shot at weight loss
about 8 hours ago
Charles Barkley is going on the offense after seeing his weight rebound...
BridgeBio's ATTR-CM med Attruby gains traction, crushes analysts' early expectations
about 8 hours ago
The company is going up against Pfizer's popular Vyndaqel franchise in the...
Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe
1 day ago
Authorities say Gilead paid honoraria payments, meals and travel expenses to induce...
AstraZeneca's highly touted Truqap flunks another phase 3 trial
1 day ago
AstraZeneca has come up short in another phase 3 trial of AKT...
Bipartisan House lawmakers try again to cut tax breaks for DTC drug ads
1 day ago
Once again, several members of Congress have come together to call for...
Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection
1 day ago
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with...
Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B
1 day ago
The company added an extra $1.7 billion to its "cost realignment" drive...
Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy
1 day ago
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least...